Preliminary results from HERKULES-1: a phase 1b/2, open-label, multicenter study of ERAS-007, an oral ERK1/2 inhibitor, in patients with advanced or metastatic solid tumors

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2022-10, Vol.174, p.S80-S81
Main Authors: Wang, J., Johnson, M., Barve, M., Pelster, M., Chen, X., Li, Z., Gordon, J., Reiss, M., Pai, S., Falchook, G., Tolcher, A.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(22)01013-9